首页 > 最新文献

Journal of Hepatology最新文献

英文 中文
From the Editor’s Desk... 来自编辑的消息
IF 26.8 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-16 DOI: 10.1016/j.jhep.2024.09.007
{"title":"From the Editor’s Desk...","authors":"","doi":"10.1016/j.jhep.2024.09.007","DOIUrl":"10.1016/j.jhep.2024.09.007","url":null,"abstract":"","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":26.8,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142439485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Submit your abstract for the EASL Congress 2025 by 3 December 在 12 月 3 日之前提交您的 2025 年 EASL 大会摘要
IF 26.8 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-16 DOI: 10.1016/S0168-8278(24)02529-7
{"title":"Submit your abstract for the EASL Congress 2025 by 3 December","authors":"","doi":"10.1016/S0168-8278(24)02529-7","DOIUrl":"10.1016/S0168-8278(24)02529-7","url":null,"abstract":"","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":26.8,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142439514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Submit your abstract for the EASL Liver Cancer Summit 2025 by 12 November 在 11 月 12 日之前提交您的 2025 年 EASL 肝癌峰会摘要
IF 26.8 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-16 DOI: 10.1016/S0168-8278(24)02530-3
{"title":"Submit your abstract for the EASL Liver Cancer Summit 2025 by 12 November","authors":"","doi":"10.1016/S0168-8278(24)02530-3","DOIUrl":"10.1016/S0168-8278(24)02530-3","url":null,"abstract":"","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":26.8,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142439515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The GENIAL consortium brings together partners with unique expertise in clinical hepatology, as well as artificial intelligence to improve diagnosis of ALD-HC GENIAL 联合会汇集了在临床肝病学和人工智能方面拥有独特专长的合作伙伴,以改进 ALD-HC 的诊断。
IF 26.8 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-16 DOI: 10.1016/S0168-8278(24)02532-7
{"title":"The GENIAL consortium brings together partners with unique expertise in clinical hepatology, as well as artificial intelligence to improve diagnosis of ALD-HC","authors":"","doi":"10.1016/S0168-8278(24)02532-7","DOIUrl":"10.1016/S0168-8278(24)02532-7","url":null,"abstract":"","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":26.8,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142439517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Frailty and risk of metabolic dysfunction–associated steatotic liver disease and other chronic liver diseases" 关于 "虚弱与代谢功能障碍相关性脂肪性肝病和其他慢性肝病的风险 "的评论
IF 25.7 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-15 DOI: 10.1016/j.jhep.2024.10.005
Yingying Cui, Xiaochun Cheng, Jingfei Wang

Section snippets

Financial support

The authors received no financial support for the research, authorship, and/or publication of this article.

Authors' contributions

Conceptualization: Yingying Cui, and Xiaochun Cheng; Writing manuscript draft: Jingfei Wang.All authors reviewed the manuscript and approved the final version.

Declaration of Competing Interest

The authors have no conflicts of interest to disclose.
章节片段财务支持作者在本文的研究、撰写和/或发表过程中未获得任何财务支持:崔莹莹和程晓春;撰写手稿:所有作者都审阅了手稿并批准了最终版本。利益冲突声明作者没有需要披露的利益冲突。
{"title":"Comment on \"Frailty and risk of metabolic dysfunction–associated steatotic liver disease and other chronic liver diseases\"","authors":"Yingying Cui, Xiaochun Cheng, Jingfei Wang","doi":"10.1016/j.jhep.2024.10.005","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.005","url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Financial support</h2>The authors received no financial support for the research, authorship, and/or publication of this article.</section></section><section><section><h2>Authors' contributions</h2>Conceptualization: Yingying Cui, and Xiaochun Cheng; Writing manuscript draft: Jingfei Wang.All authors reviewed the manuscript and approved the final version.</section></section><section><section><h2>Declaration of Competing Interest</h2>The authors have no conflicts of interest to disclose.</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":25.7,"publicationDate":"2024-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142439513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acknowledging our reviewers 感谢审稿人
IF 25.7 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-12 DOI: 10.1016/j.jhep.2024.10.007
No Abstract
无摘要
{"title":"Acknowledging our reviewers","authors":"","doi":"10.1016/j.jhep.2024.10.007","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.10.007","url":null,"abstract":"No Abstract","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":25.7,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142415783","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MicroRNA-107 – a small RNA with a big impact on cytokinesis in hepatocellular carcinoma MicroRNA-107--对肝细胞癌细胞分裂有重大影响的小 RNA
IF 25.7 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-11 DOI: 10.1016/j.jhep.2024.09.045
Xiaowei Zhong, Michael Ott, Amar Deep Sharma, Asha Balakrishnan
Authors declare no conflict of interest related to this study
Figure 1
  1. Download: Download high-res image (832KB)
  2. Download: Download full-size image

Figure 1. miR-107/KIF23 axis as a key regulator of HCC development

In normal liver tissue, high levels of the hepatocyte-enriched-miR-107 inhibit Kif23 translation. MiR-107 expression is downregulated in HCC resulting in enhanced KIF23 translation. This enables abnormal proliferation of HCC cells. Both, overexpression of miR-107 or knockdown of KIF23 induces failed assembly of mitotic spindle, cytokinesis failure and subsequently inhibits tumour development. (Figure created with BioRender.com).
作者声明与本研究无利益冲突下载:下载高清图片 (832KB)Download:图 1:miR-107/KIF23 轴是 HCC 发展的关键调控因子在正常肝组织中,高水平的肝细胞富集-miR-107 可抑制 Kif23 翻译。在 HCC 中,MiR-107 表达下调,导致 KIF23 翻译增强。这使得 HCC 细胞异常增殖。过表达 miR-107 或敲除 KIF23 都会导致有丝分裂纺锤体组装失败、细胞分裂失败,进而抑制肿瘤的发展。(图由 BioRender.com 绘制)。
{"title":"MicroRNA-107 – a small RNA with a big impact on cytokinesis in hepatocellular carcinoma","authors":"Xiaowei Zhong, Michael Ott, Amar Deep Sharma, Asha Balakrishnan","doi":"10.1016/j.jhep.2024.09.045","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.09.045","url":null,"abstract":"Authors declare no conflict of interest related to this study<figure><span><img alt=\"Figure 1\" aria-describedby=\"cap0010\" height=\"443\" src=\"https://ars.els-cdn.com/content/image/1-s2.0-S0168827824026242-gr1.jpg\"/><ol><li><span><span>Download: <span>Download high-res image (832KB)</span></span></span></li><li><span><span>Download: <span>Download full-size image</span></span></span></li></ol></span><span><span><p><span>Figure 1</span>. miR-107/KIF23 axis as a key regulator of HCC development</p>In normal liver tissue, high levels of the hepatocyte-enriched-miR-107 inhibit Kif23 translation. MiR-107 expression is downregulated in HCC resulting in enhanced KIF23 translation. This enables abnormal proliferation of HCC cells. Both, overexpression of miR-107 or knockdown of KIF23 induces failed assembly of mitotic spindle, cytokinesis failure and subsequently inhibits tumour development. (Figure created with <span><span>BioRender.com</span><svg aria-label=\"Opens in new window\" focusable=\"false\" height=\"20\" viewbox=\"0 0 8 8\"><path d=\"M1.12949 2.1072V1H7V6.85795H5.89111V2.90281L0.784057 8L0 7.21635L5.11902 2.1072H1.12949Z\"></path></svg></span>).</span></span></figure>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":25.7,"publicationDate":"2024-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142405572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Etymology of Liver in Ancient Greek and Latin 古希腊语和拉丁语中 "肝 "的词源
IF 25.7 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-10 DOI: 10.1016/j.jhep.2024.09.042
John Henry, Marvad Ahad
No Abstract
无摘要
{"title":"The Etymology of Liver in Ancient Greek and Latin","authors":"John Henry, Marvad Ahad","doi":"10.1016/j.jhep.2024.09.042","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.09.042","url":null,"abstract":"No Abstract","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":25.7,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142398468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PNPLA3 rs738409, environmental factors and liver-related mortality in the U.S. Population 美国人口中的 PNPLA3 rs738409、环境因素和肝脏相关死亡率
IF 25.7 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.jhep.2024.09.043
Eduardo Vilar-Gomez, Samer Gawrieh, Raj Vuppalanchi, Carla Kettler, Francis Pike, Niharika Samala, Naga Chalasani

Background & Aims

Little is known about the interplay between patatin-like phospholipase domain protein 3 (PNPLA3 rs738409 C>G), environmental factors, and the risk of liver-related death (LRD).

Methods

4,361 adults were selected from NHANES III, 1991–1994. All participants were linked to the National Death Index until 2019 (mean follow-up: 23.2 years). LRD was the study outcome. Associations of PNPLA3, diet, light alcohol intake, smoking, and BMI (kg/m2) with LRD were examined using competing risk regression models.

Results

PNPLA3 G–allele was significantly associated with LRD (adjusted subhazard ratio [adj.sHR]: 2.9, 95% CI: 1.4-5.8). Non-heavy alcohol intake (adj.sHR: 2.2, 95% CI: 1.1-4.5), top quartiles of monounsaturated fat (MUFA) (adj.sHR: 0.43, 95% CI: 0.12-0.99), and cholesterol (adj.sHR: 2.6, 95% CI: 1.00-8.8) and coffee intake ≥3 cups/day (adj.sHR: 0.05, 95% CI: 0.06-0.10), former/current smoking (adj.sHR: 1.8, 95% CI: 1.2-2.6), BMI (adj.sHR: 1.1, 95% CI: 1.03-1.2), and healthy eating index (HEI) (adj.sHR: 0.96, 95% CI: 0.93-0.98) were associated with LRD.Joint effects between PNPLA3 and environmental factors showed that the risk of LRD was significantly increased in carriers of the G-allele with non-heavy alcohol intake (adj.sHR: 3.7), higher consumption (top quartile) of cholesterol (adj.sHR: 4.1), former (adj.sHR: 4.3) or current (adj.sHR: 3.5) smoking, or BMI ≥30 (adj.sHR: 4.0) kg/m2. The effects of the G-allele on the risk of LRD were significantly attenuated in those with top quartile consumption of MUFA (adj.sHR: 0.5) or ≥3 cups/day of coffee (adj.sHR: 0.09). HEI was inversely associated with LRD across all PNPLA3 genotypes (adj.sHR: 0.94, 0.96, and 0.97 for CC, CG, and GG, respectively).

Conclusions

PNPLA3 is associated with LRD and this relationship is significantly modified by anthropometric and environmental factors.
背景&目的人们对棒蛋白样磷脂酶结构域蛋白3(PNPLA3 rs738409 C>G)、环境因素和肝脏相关死亡(LRD)风险之间的相互作用知之甚少。所有参与者都与国家死亡指数建立了链接,直至 2019 年(平均随访时间:23.2 年)。LRD是研究结果。使用竞争风险回归模型研究了 PNPLA3、饮食、轻度酒精摄入量、吸烟和体重指数(kg/m2)与 LRD 的关系。结果PNPLA3 G-等位基因与 LRD 显著相关(调整后次危险比 [adj.sHR]:2.9,95% CI:1.4-5.8)。非大量酒精摄入量(adj.sHR:2.2,95% CI:1.1-4.5)、单不饱和脂肪(MUFA)最高四分位数(adj.sHR:0.43,95% CI:0.12-0.99)、胆固醇(adj.sHR:2.6,95% CI:1.00-8.8)、咖啡摄入量≥3 杯/天(adj.sHR:0.05,95% CI:0.06-0.10)、曾经/目前吸烟(adj.sHR:1.8,95% CI:1.2-2.6)、体重指数(adj.sHR:1.1,95% CI:1.03-1.2)和健康饮食指数(HEI)(adj.sHR:0.PNPLA3和环境因素之间的联合效应显示,非大量酒精摄入的G-等位基因携带者罹患LRD的风险显著增加(adj.PNPLA3与环境因素的联合效应显示,非大量饮酒(adj.sHR:3.7)、胆固醇摄入量较高(前四分之一)(adj.sHR:4.1)、曾经(adj.sHR:4.3)或目前(adj.sHR:3.5)吸烟或体重指数≥30(adj.sHR:4.0)kg/m2的G等位基因携带者的LRD风险明显增加。G-等位基因对 LRD 风险的影响在 MUFA 消费量居前四分之一(adj.sHR:0.5)或咖啡饮用量≥3 杯/天(adj.sHR:0.09)的人群中明显减弱。在所有 PNPLA3 基因型中,HEI 与 LRD 都呈反比关系(CC、CG 和 GG 的 adj.sHR 分别为 0.94、0.96 和 0.97)。
{"title":"PNPLA3 rs738409, environmental factors and liver-related mortality in the U.S. Population","authors":"Eduardo Vilar-Gomez, Samer Gawrieh, Raj Vuppalanchi, Carla Kettler, Francis Pike, Niharika Samala, Naga Chalasani","doi":"10.1016/j.jhep.2024.09.043","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.09.043","url":null,"abstract":"<h3>Background &amp; Aims</h3>Little is known about the interplay between patatin-like phospholipase domain protein 3 <em>(PNPLA3</em> rs738409 C&gt;G), environmental factors, and the risk of liver-related death (LRD).<h3>Methods</h3>4,361 adults were selected from NHANES III, 1991–1994. All participants were linked to the National Death Index until 2019 (mean follow-up: 23.2 years). LRD was the study outcome. Associations of <em>PNPLA3</em>, diet, light alcohol intake, smoking, and BMI (kg/m<sup>2</sup>) with LRD were examined using competing risk regression models.<h3>Results</h3><em>PNPLA3</em> G–allele was significantly associated with LRD (adjusted subhazard ratio [adj.sHR]: 2.9, 95% CI: 1.4-5.8). Non-heavy alcohol intake (adj.sHR: 2.2, 95% CI: 1.1-4.5), top quartiles of monounsaturated fat (MUFA) (adj.sHR: 0.43, 95% CI: 0.12-0.99), and cholesterol (adj.sHR: 2.6, 95% CI: 1.00-8.8) and coffee intake ≥3 cups/day (adj.sHR: 0.05, 95% CI: 0.06-0.10), former/current smoking (adj.sHR: 1.8, 95% CI: 1.2-2.6), BMI (adj.sHR: 1.1, 95% CI: 1.03-1.2), and healthy eating index (HEI) (adj.sHR: 0.96, 95% CI: 0.93-0.98) were associated with LRD.Joint effects between <em>PNPLA3</em> and environmental factors showed that the risk of LRD was significantly increased in carriers of the G-allele with non-heavy alcohol intake (adj.sHR: 3.7), higher consumption (top quartile) of cholesterol (adj.sHR: 4.1), former (adj.sHR: 4.3) or current (adj.sHR: 3.5) smoking, or BMI ≥30 (adj.sHR: 4.0) kg/m<sup>2</sup>. The effects of the G-allele on the risk of LRD were significantly attenuated in those with top quartile consumption of MUFA (adj.sHR: 0.5) or ≥3 cups/day of coffee (adj.sHR: 0.09). HEI was inversely associated with LRD across all <em>PNPLA3</em> genotypes (adj.sHR: 0.94, 0.96, and 0.97 for CC, CG, and GG, respectively).<h3>Conclusions</h3><em>PNPLA3</em> is associated with LRD and this relationship is significantly modified by anthropometric and environmental factors.","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":25.7,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142397797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CXCL12+ Tumor-associated Endothelial Cells Promote Immune Resistance in Hepatocellular Carcinoma. CXCL12+肿瘤相关内皮细胞增强肝细胞癌的免疫抵抗力
IF 25.7 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-09 DOI: 10.1016/j.jhep.2024.09.044
Yajie Lu, Yunpeng Liu, Xiaoshuang Zuo, Guodong Li, Jianlin Wang, Jianshan Liu, Xiangxu Wang, Shuning Wang, Wangqian Zhang, Kuo Zhang, Xiaoying Lei, Qiang Hao, Weina Li, Lei Liu, Meng Li, Cun Zhang, Hongmei Zhang, Yingqi Zhang, Yuan Gao

Background

The tumor microenvironment (TME) plays a crucial role in the limited efficacy of existing treatments for hepatocellular carcinoma (HCC), with tumor-associated endothelial cells (TECs) serving as fundamental TME components that substantially influence tumor progression and treatment efficacy. However, the precise roles and mechanisms of TECs in HCC remain inadequately understood.

Methods

We employed a multi-omics profiling strategy to investigate the single-cell and spatiotemporal evolution of TECs within the microenvironment of HCC tumors showcasing varied responses to immunotherapy. Through an analysis of a clinical cohort of HCC patients, we explored the correlation between TEC subpopulations and immunotherapy outcomes. The influence of TEC subsets on the immune microenvironment was confirmed through comprehensive in vitro and in vivo studies. To further explore the mechanisms of distinct TEC subpopulations in microenvironmental modulation and their impact on immunotherapy, we utilized TEC subset-specific knockout mouse models as well as humanized mouse models.

Results

In this research, we identified a new subset of CXCL12+ TECs that exert a crucial role in immune suppression within the HCC TME. Functionally, CXCL12+ TECs impede the differentiation of CD8+ naïve T cells into CD8+ cytotoxic T cells by secreting CXCL12. Furthermore, they attract myeloid-derived suppressor cells (MDSCs). A bispecific antibody was developed to target both CXCL12 and PD1 specifically, showing significant promise in bolstering anti-tumor immune responses and advancing HCC therapy.

Conclusions

CXCL12+ TECs are pivotal in mediating immunosuppression within HCC microenvironment and targeting CXCL12+ TECs presents a promising approach to augment the efficacy of immunotherapies in HCC patients.

Impact and implication

This investigation reveals a pivotal mechanism in the HCC TME, where CXCL12+ TECs emerge as crucial modulators of immune suppression. The discovery of CXCL12+ TECs as inhibitors of CD8+ naïve T cell activation and recruiters of MDSCs significantly advances our grasp of the dynamic between HCC and immune regulation. Moreover, the development and application of a bispecific antibody precisely targeting CXCL12 and PD1 has proven to enhance immune responses in a humanized mouse HCC model. This finding underscores a promising therapeutic direction for HCC, offering the potential to amplify the impact of current immunotherapies.
背景肿瘤微环境(TME)在现有肝细胞癌(HCC)治疗方法的有限疗效中起着至关重要的作用,而肿瘤相关内皮细胞(TECs)是肿瘤微环境的基本组成部分,对肿瘤的进展和疗效有重大影响。我们采用多组学分析策略,研究了对免疫疗法有不同反应的HCC肿瘤微环境中TECs的单细胞和时空演变。通过分析 HCC 患者的临床队列,我们探索了 TEC 亚群与免疫疗法结果之间的相关性。通过全面的体外和体内研究,证实了TEC亚群对免疫微环境的影响。为了进一步探索不同 TEC 亚群在微环境调控中的作用机制及其对免疫治疗的影响,我们利用了 TEC 亚群特异性基因敲除小鼠模型和人源化小鼠模型。结果在这项研究中,我们发现了一个新的 CXCL12+ TEC 亚群,它们在 HCC TME 内的免疫抑制中发挥着关键作用。在功能上,CXCL12+ TECs通过分泌CXCL12阻碍CD8+幼稚T细胞分化为CD8+细胞毒性T细胞。此外,它们还能吸引髓源性抑制细胞(MDSCs)。我们开发出了一种双特异性抗体,可同时特异性地靶向 CXCL12 和 PD1,在增强抗肿瘤免疫反应和促进 HCC 治疗方面显示出了巨大的前景。结论CXCL12+ TECs 在介导 HCC 微环境中的免疫抑制方面起着关键作用,靶向 CXCL12+ TECs 是增强 HCC 患者免疫疗法疗效的一种很有前景的方法。影响和意义这项研究揭示了 HCC TME 中的一种关键机制,CXCL12+ TECs 在其中成为免疫抑制的关键调节因子。CXCL12+ TECs 是 CD8+ 幼稚 T 细胞活化的抑制剂和 MDSCs 的招募者,这一发现极大地推动了我们对 HCC 与免疫调节之间动态关系的了解。此外,在人源化小鼠 HCC 模型中,精确靶向 CXCL12 和 PD1 的双特异性抗体的开发和应用已被证明能增强免疫反应。这一发现强调了治疗 HCC 的一个有前途的方向,为扩大目前免疫疗法的影响提供了可能性。
{"title":"CXCL12+ Tumor-associated Endothelial Cells Promote Immune Resistance in Hepatocellular Carcinoma.","authors":"Yajie Lu, Yunpeng Liu, Xiaoshuang Zuo, Guodong Li, Jianlin Wang, Jianshan Liu, Xiangxu Wang, Shuning Wang, Wangqian Zhang, Kuo Zhang, Xiaoying Lei, Qiang Hao, Weina Li, Lei Liu, Meng Li, Cun Zhang, Hongmei Zhang, Yingqi Zhang, Yuan Gao","doi":"10.1016/j.jhep.2024.09.044","DOIUrl":"https://doi.org/10.1016/j.jhep.2024.09.044","url":null,"abstract":"<h3>Background</h3>The tumor microenvironment (TME) plays a crucial role in the limited efficacy of existing treatments for hepatocellular carcinoma (HCC), with tumor-associated endothelial cells (TECs) serving as fundamental TME components that substantially influence tumor progression and treatment efficacy. However, the precise roles and mechanisms of TECs in HCC remain inadequately understood.<h3>Methods</h3>We employed a multi-omics profiling strategy to investigate the single-cell and spatiotemporal evolution of TECs within the microenvironment of HCC tumors showcasing varied responses to immunotherapy. Through an analysis of a clinical cohort of HCC patients, we explored the correlation between TEC subpopulations and immunotherapy outcomes. The influence of TEC subsets on the immune microenvironment was confirmed through comprehensive in vitro and in vivo studies. To further explore the mechanisms of distinct TEC subpopulations in microenvironmental modulation and their impact on immunotherapy, we utilized TEC subset-specific knockout mouse models as well as humanized mouse models.<h3>Results</h3>In this research, we identified a new subset of CXCL12<sup>+</sup> TECs that exert a crucial role in immune suppression within the HCC TME. Functionally, CXCL12<sup>+</sup> TECs impede the differentiation of CD8<sup>+</sup> naïve T cells into CD8<sup>+</sup> cytotoxic T cells by secreting CXCL12. Furthermore, they attract myeloid-derived suppressor cells (MDSCs). A bispecific antibody was developed to target both CXCL12 and PD1 specifically, showing significant promise in bolstering anti-tumor immune responses and advancing HCC therapy.<h3>Conclusions</h3>CXCL12<sup>+</sup> TECs are pivotal in mediating immunosuppression within HCC microenvironment and targeting CXCL12<sup>+</sup> TECs presents a promising approach to augment the efficacy of immunotherapies in HCC patients.<h3>Impact and implication</h3>This investigation reveals a pivotal mechanism in the HCC TME, where CXCL12<sup>+</sup> TECs emerge as crucial modulators of immune suppression. The discovery of CXCL12<sup>+</sup> TECs as inhibitors of CD8<sup>+</sup> naïve T cell activation and recruiters of MDSCs significantly advances our grasp of the dynamic between HCC and immune regulation. Moreover, the development and application of a bispecific antibody precisely targeting CXCL12 and PD1 has proven to enhance immune responses in a humanized mouse HCC model. This finding underscores a promising therapeutic direction for HCC, offering the potential to amplify the impact of current immunotherapies.","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":null,"pages":null},"PeriodicalIF":25.7,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142397733","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Hepatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1